GlassScriptPhysician profile
Albert S Katz
NPI 1306827522
$658.14
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $40.15 · 2021: $111 · 2022: $94.22 · 2023: $258 · 2024: $22.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $280.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $129.43 | 2019-2023 | Erleada |
| Astellas Pharma US INC | $101.63 | 2019-2023 | Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $83.49 | 2021-2023 | |
| Myovant Sciences INC. | $42.54 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $41.09 | 2023 | Orgovyx |
| Halozyme INC | $33.49 | 2023 | |
| Abbvie INC. | $30.40 | 2019-2022 | |
| Verity Pharmaceuticals INC. | $28.13 | 2023 | Trelstar |
| Progenics Pharmaceuticals, INC. | $27.89 | 2023 | Pylarify |
| Blue Earth Diagnostics | $24.66 | 2019 | |
| Endo Pharmaceuticals INC. | $23.00 | 2019 | |
| Coloplast Corp | $22.59 | 2024 | |
| Clarus Therapeutics INC. | $20.36 | 2021 | |
| Antares Pharma, INC. | $18.06 | 2022 | |
| Acerus Pharmaceuticals Corporation | $17.18 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $14.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Albert Katz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.